Differences in conformation of type 3 poliovirus antigenic sites on non-infectious empty particles and infectious virus

References

1. Brown E., Sheppard R. C., Williams B. J. 1983; Peptide synthesis. Part 5. Solid-phase synthesis of (15-leucine) little gastrin. Journal of the Chemical Society Perkins Transactions 1:1161–1167
   [Google Scholar]
2. Ferguson M., Minor P. D., Magrath D. I., Qui Y.-H., Spitz M., Schild G. C. 1984; Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies. Journal of General Virology 65:197–201
   [Google Scholar]
3. Ferguson M., Evans D. M. A., Magrath D. I., Minor P. D., Almond J. W., Schild G. C. 1985; Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3. Virology 143:505–515
   [Google Scholar]
4. Fernandez-Tomas C. B., Baltimore D. 1973; Morphogenesis of poliovirus. II. Demonstration of a new intermediate, the provirion. Journal of Virology 12:1122–1130
   [Google Scholar]
5. Filman D. J., Syed R., Chow M., Macadam A. J., Minor P. D., Hogle J. M. 1989; Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO Journal 8:1567–1579
   [Google Scholar]
6. Hogle J. M., Chow M., Filman D. J. 1985; The three dimensional structure of poliovirus at 2·9 Å resolution. Science 229:1358–1365
   [Google Scholar]
7. Mayer M. M., Rapp H. J., Roizman B., Klein S. W., Cowan K. M., Lukens D., Schwerdt C. E., Schaffer F. L., Charney J. 1957; The purification of poliomyelitis virus as studied by complement fixation. Journal of Immunology 78:435–455
   [Google Scholar]
8. Minor P. D., Schild G. C., Wood J. M., Dandawate C. N. 1980; The preparation of specific immune sera against type 3 poliovirus D-antigen and C-antigen and the demonstration of two C-antigenic components in vaccine strain populations. Journal of General Virology 51:147–156
   [Google Scholar]
9. Minor P. D., Schild G. C., Bootman J., Evans D. M. A., Ferguson M., Reeve P., Spitz M., Stanway G., Cann A. J., Hauptmann R., Clarke L. D., Mountford R. C., Almond J. W. 1983; Location and primary structure of a major antigenic site for poliovirus neutralization. Nature; London: 301674–679
   [Google Scholar]
10. Minor P. D., Evans D. M. A., Ferguson M., Schild G. C., Westrop G., Almond J. W. 1985; Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. Journal of General Virology 66:1159–1165
    [Google Scholar]
11. Minor P. D., Ferguson M., Evans D. M. A., Almond J. W., Icenogle J. P. 1986; Antigenic structure of polioviruses of serotypes 1, 2 and 3. Journal of General Virology 67:1283–1291
    [Google Scholar]
12. Minor P. D., Ferguson M., Phillips A., Magrath D. I., Huovilainen A., Hovi T. 1987; Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. Journal of General Virology 68:1857–1865
    [Google Scholar]
13. Page G. S., Mosser A. G., Hogle J. M., Filman D. J., Rueckert R. R., Chow M. 1988; Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. Journal of Virology 62:1781–1794
    [Google Scholar]
14. Schild G. C., Wood J. M., Minor P. D., Dandawate C. N., Magrath D. I. 1980; Immunoassay of poliovirus antigens by single-radial-diffusion: development and characteristics of sensitive autoradiographic zone size enhancement (ZE) technique. Journal of General Virology 51:157–170
    [Google Scholar]
15. Wiegers K. J., Uhlig H., Dernick R. 1989; N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152. Virology 170:583–586
    [Google Scholar]